Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction

INTRODUCTION: Epilepsy patients with intellectual disability often suffer from drug-resistant epilepsy (DRE), which severely affects patients’ quality of life. Cenobamate (CNB) is a recently approved novel and effective ASM that can achieve high rates of seizure freedom in previously drug-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedo, Anna-Lena, Greshake, Benedikt, Makridis, Konstantin L., Straub, Hans-Beatus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390252/
https://www.ncbi.nlm.nih.gov/pubmed/37528853
http://dx.doi.org/10.3389/fneur.2023.1209487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390252/
https://www.ncbi.nlm.nih.gov/pubmed/37528853
http://dx.doi.org/10.3389/fneur.2023.1209487

Ejemplares similares